Cancer cachexia therapeutics [ 2017 - 2018 ]

Research Grant

Researchers: Prof Nick Hoogenraad (Principal investigator) ,  A/Pr Hamsa Puthalakath ,  Dr Amelia Johnston ,  Dr Megan Maher ,  Prof Andrew Scott
View all 6 related researchers

Brief description We have discovered a single tumour factor which causes cancer cachexia, a wasting condition that is one of the worst complications of malignancy, for which there is no current effective treatment. We have developed antibodies which effectively block this condition in preclinical models and have produced human/humanised version of this. This application is to characterise these human antibodies to allow us proceed to clinical trials.

Funding Amount $AUD 639,653.26

Funding Scheme Development Grants

Notes Development Grant